Calithera Biosciences Prices IPO At $10/shr - Quick Facts

(RTTNews) - Calithera Biosciences Inc. (CALA), a clinical-stage pharmaceutical company, announced Thursday that it priced its initial public offering of 8.00 million shares of common stock at $10.00 per share.

The common stock of Calithera Biosciences, Inc. has been approved for listing on the NASDAQ Global Select Market and is expected to begin trading under the ticker symbol "CALA" on October 2, 2014.

All of the common stock is being offered by Calithera Biosciences, Inc. In addition, Calithera Biosciences, Inc. has granted the underwriters a 30-day option to purchase up to 1.20 million additional shares of common stock.

Citigroup and Leerink Partners are acting as joint book-running managers for the offering. Wells Fargo Securities and JMP Securities are acting as co-managers for the offering.